ZAI LAB LTD's ticker is ZLAB and the CUSIP is 98887Q104. A total of 223 filers reported holding ZAI LAB LTD in Q3 2021. The put-call ratio across all filers is 1.79 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | – | 30,113 | 0.0% | 0.00% | – |
| Q2 2023 | $0 | – | 30,113 | +129.5% | 0.00% | – |
| Q1 2023 | $0 | -100.0% | 13,121 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $449 | -99.9% | 13,121 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $449,000 | -1.3% | 13,121 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $455,000 | -21.1% | 13,121 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $577,000 | -30.1% | 13,121 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $825,000 | -20.1% | 13,121 | +34.0% | 0.00% | -25.0% |
| Q3 2021 | $1,032,000 | -70.2% | 9,793 | -50.0% | 0.00% | -33.3% |
| Q2 2021 | $3,466,000 | +47.6% | 19,586 | +11.3% | 0.01% | +20.0% |
| Q1 2021 | $2,348,000 | -84.7% | 17,602 | -14.8% | 0.01% | -28.6% |
| Q4 2020 | $15,383,000 | +1780.6% | 20,666 | +110.3% | 0.01% | +250.0% |
| Q3 2020 | $818,000 | +1.2% | 9,826 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $808,000 | – | 9,826 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Genesis Investment Management, LLP | 1,032,166 | $25,091,955 | 3.50% |
| XY Capital Ltd | 139,743 | $3,397,152 | 1.95% |
| Paradigm Biocapital Advisors LP | 1,142,383 | $27,771,331 | 1.88% |
| Privium Fund Management B.V. | 240,683 | $5,851,004 | 1.74% |
| Segantii Capital Management Ltd | 1,788,999 | $43,262,801 | 1.52% |
| Vivo Capital, LLC | 454,606 | $11,051,472 | 1.21% |
| BRILLIANCE ASSET MANAGEMENT LTD | 157,085 | $3,818,736 | 0.96% |
| Capricorn Fund Managers Ltd | 100,967 | $2,454,508 | 0.85% |
| Rock Springs Capital Management LP | 1,237,023 | $30,072,029 | 0.81% |
| Long Corridor Asset Management Ltd | 31,000 | $753,610 | 0.66% |